NS Healthcare is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
Home » whitepapers » Haselmeier announces the launch of INSUPen® EZ in India by Biocon

White Paper

Haselmeier announces the launch of INSUPen® EZ in India by Biocon

Haselmeier announces that Biocon, one of Asia’s premier biotechnology companies, has just launched INSUPen® EZ in India. The INSUPen® EZ is a second generation pen and follows on the successes of Biocon’s premier insulin delivery device INSUPen®.

Download to find out more.

Download White Paper